MedTrace Logo

A Registered Cohort Study on SMA

NCT04010604 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-09-23

No results posted yet for this study

Summary

Spinal muscular atrophy (SMA) is an autosomal recessive disease that causes progressive muscle wasting and weakness due to loss of motor neurons in the spinal cord. This is a registered cohort of spinal muscular atrophy (SMA) type I，II and III in China. This study will provide further insights into the clinical course of SMA including overall survival, demographic characteristics, motor function, respiratory support, feeding and nutritional support, growth and development. The correlation of genotype and phenotype will be conducted.

Conditions

Sponsors & Collaborators

  • Wan-Jin Chen

    lead OTHER

Eligibility

Min Age
1 Week
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2039-12-31
Completion
2049-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010604 on ClinicalTrials.gov